Aardvark Therapeutics, Inc. Common Stock (AARD) Q4 2024 Annual Earnings
AARD·Reported February 26, 2025
Diluted EPS came in at $-0.68, missed the $-0.41 consensus by $0.27.
Diluted EPS
$-0.68missed by $0.27
Consensus: $-0.41
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Aardvark Therapeutics, Inc. Common Stock's Q4 2024 earnings report.
Aardvark Therapeutics, Inc. Common Stock (AARD) reported Q4 2024 earnings on February 26, 2025.
Aardvark Therapeutics, Inc. Common Stock reported diluted EPS of $-0.68 for Q4 2024.
EPS missed the consensus estimate of $-0.41 by $0.27.
You can read the 10-K periodic report (0000950170-25-047835) directly on SEC EDGAR. The filing index links above go to sec.gov.